What You Should Know:
- Paige secures an additional $15M from Goldman Sachs totaling $20M to close out a total Series B funding round of $70M for its AI-native digital pathology ecosystem.
- The company’s continued product portfolio of innovation in telepathology and digital diagnostics accelerated by further investment.
Paige, an NYC-based leader in computational pathology transforming the diagnosis and treatment of cancer, today announced it received an additional $15M from
Read More
Clinical Trial
COVID-19 Has Permanently Shifted Patient Behavior Towards Virtual Care
What You Should Know:
- The COVID-19 crisis has significantly impacted the
patient care paradigm, and the ripple effects have altered patient behaviors
and expectations, requiring a significant change in how life sciences companies
engage with and support patients
- Accenture surveyed 2700 patients about changes in care
during COVID-19 and found a major shift to virtual care, which patients
embraced.
- Virtual care is here to stay and can be an integral
part of the patient experience
Read More
Scripps Research, Repurpose.AI Partner to Develop COVID-19 Therapeutics
What You Should Know:
- Repurpose.AI, has partnered with Scripps Research to
discover drug candidates that may be repurposed to treat COVID-19.
- The partnership will leverage Repurpose.AI's ActivPred
AI Drug Discovery Platform, an unbiased drug, target, and disease agnostic
digital chemistry engine, to discover drug candidates to treat COVID-19.
Scripps Research is
teaming up with Repurpose.AI, an AI
drug discovery company to develop COVID-19 therapeutics. The
Read More
MD Anderson, Philips Partner on Personalized Oncology Treatments, Clinical Trial Matching
What You Should Know:
- Philips and MD Anderson collaborate to facilitate
personalized oncology treatments and clinical trial matching based on genomic
markers.
- Philips connects oncologists and pathologists around
the world to MD Anderson’s Precision Oncology Decision Support (PODS) system of
actionable clinical information
Philips and The University of Texas MD Anderson Cancer
Center today announced a collaboration to provide oncologists with
evidence-based therapy and clinical
Read More
Consumer Genetic Tests Accelerate Precision Medicine for Some Providers
Joel Diamond, MD, FAAFP, Chief Medical Officer at 2bPrecise
Direct-to-consumer (DTC) genetic tests have been on the scene for some time now. The Federal Drug Administration (FDA) approved the first DTC test on three specific BRCA1/BRCA2 breast cancer gene mutations more than two years ago. Six months after that, the agency similarly green-lighted a DTC pharmacogenomic (PGx) test to examine 33 variants for eight different genes that indicate how effectively patients metabolize specific
Read More
COVID-19 Clinical Trials: How AI-Based Chatbots Can Provide Pandemic-Level Execution
Greg Kefer, Chief Marketing Officer, LifeLink
More than 500 new COVID-19 related clinical trials have been registered as of the end of April. The race to find a COVID-19 vaccine is on and the public spotlight is on clinical trials. Strangely named drugs such as Hydroxychloroquine and Remdesivir have become household names and are featured and debated regularly on the 24-hour news channels.
The pressure to find a cure is intense. The locked-down world does not want to hear that at
Read More
Sharecare Acquires Evidence-Based Behavior Change Apps MindSciences
What You Should Know:
- Sharecare announced the acquisition of Boston-based MindSciences, an evidence-based behavior change suite of apps focused on mental health (anxiety, stress management), smoking cessation, and weight loss/binge eating, and more.
- The acquisition rounds out Sharecare’s portfolio of mHealth-based therapeutic programs improving chronic disease risk and overall health outcomes by targeting varying aspects of well-being.
- Based on the work of Dr. Judson Brewer, now
Read More
Syapse Lands $30M to Accelerate Real-World Evidence in Oncology
What You Should Know:
- Syapse raises $30M in new equity funding to enable healthcare providers to deliver the best care to every cancer patient through precision medicine.
- Syapse partners with health systems, life sciences companies, and regulators to deliver clinical, programmatic, and research insights from the world’s largest network of health systems focused on precision medicine.
Syapse, a San
Francisco, CA-based provider of precision oncology
solutions announced $30
Read More
Inovalon Launches FHIR-Based Solution for Health Plan Compliance
What You Should Know:
- Inovalon announced the availability of its Cloud-Based “Consumer Health Gateway” Module, alleviating the need for health plans to build their own Patient Access API to comply with the new requirement of the 21st Century Cures Act.
- The Consumer Health Gateway is a consumer portal allowing the FHIR®-based exchange of a patient’s claims and clinical data securely with authorized third-party applications. It consists of a robust patient consent and authentication
Read More
Philips Launches HealthSuite Clinical Trial Accelerator
What You Should Know:
Philips launches HealthSuite Clinical Trial Accelerator
to help life science organizations run more flexible, patient-centric clinical
trials.
Clinical Trial Accelerator enables patient-centric trials
at home, managing the collection of data while providing the security and
compliance expected from both patients and life science organizations.
Philips, today
announced Clinical
Trial Accelerator on Philips HealthSuite. This new tailored set of
capabilities
Read More
